Comments
Celsion CEO says ThermoDox a $1 billion product
20.06.2012. | NEW YORK (Reuters) - Michael Tardugno, chief executive of tiny Celsion Corp, is convinced he has a $1 billion cancer therapy on his hands with its ThermoDox treatment for liver cancer....